The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Inhibition of polo-like kinase 1 (PLK1) in endocrine-resistant ER+ breast cancer.
Valerie Malyvanh Jansen
No relevant relationships to disclose
Neil E Bhola
No relevant relationships to disclose
Sangeeta Bafna
No relevant relationships to disclose
Jennifer Margaret Giltnane
No relevant relationships to disclose
Justin M. Balko
No relevant relationships to disclose
Teresa C Dugger
No relevant relationships to disclose
Carlos L. Arteaga
No relevant relationships to disclose